Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
28 January 2021Website:
http://hyperfine.ioNext earnings report:
08 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 20:07:32 GMTDividend
Analysts recommendations
Institutional Ownership
HYPR Latest News
Hyperfine announces a publication on using the Swoop system for patients on ECMO support. The study showed the safety of using an ultra-low-field portable brain MRI on patients undergoing ECMO.
Compared to conventional MRI, which takes an average of 27.7 hours, the Swoop system of HYPR operates with a median time-to-scan of 2.5 hours.
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced a collaboration with the Medical University of South Carolina to assess the brains of astronauts before and after embarking on the Polaris Dawn mission. Researchers will utilize the Swoop® Portable MR Imaging® system at a SpaceX facility in.
Hyperfine, Inc. (NASDAQ:HYPR ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon, and welcome to Hyperfine's Second Quarter 2024 Earnings Conference Call.
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.
Hyperfine (HYPR) announces the receipt of FDA clearance for its ninth-generation AI-powered Swoop system software.
Hyperfine (HYPR) announces that it has signed agreements with experienced and accomplished distributors in Germany, Austria, Switzerland, and key Nordic markets for its Swoop, a portable MRI system.
Hyperfine, Inc. (NASDAQ: HYPR) will be holding its Q1 2024 Earnings Conference Call on May 13, 2024 at 4:30 PM ET. The call will be led by Marissa Bych from Gilmartin Group, Investor Relations, Maria Sainz, President and CEO, and Brett Hale, CAO and CFO. Xuyang Li from Jefferies will also be present. Good afternoon, and thank you for joining the Hyperfine's Q1 2024 Earnings Conference Call. All participants are currently in listen-only mode.
Hyperfine, Inc. (HYPR) reported a quarterly loss of $0.14 per share, which was in line with the Zacks Consensus Estimate and an improvement from the loss of $0.17 per share in the same quarter last year.
Hyperfine (HYPR) lacks the necessary ingredients for a potential earnings beat in its upcoming report. Be sure to have the key expectations in mind.
What type of business is Hyperfine?
Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.
What sector is Hyperfine in?
Hyperfine is in the Healthcare sector
What industry is Hyperfine in?
Hyperfine is in the Medical Devices industry
What country is Hyperfine from?
Hyperfine is headquartered in United States
When did Hyperfine go public?
Hyperfine initial public offering (IPO) was on 28 January 2021
What is Hyperfine website?
https://hyperfine.io
Is Hyperfine in the S&P 500?
No, Hyperfine is not included in the S&P 500 index
Is Hyperfine in the NASDAQ 100?
No, Hyperfine is not included in the NASDAQ 100 index
Is Hyperfine in the Dow Jones?
No, Hyperfine is not included in the Dow Jones index
When was Hyperfine the previous earnings report?
No data
When does Hyperfine earnings report?
The next expected earnings date for Hyperfine is 08 November 2024